跳至主要内容
临床试验/CTRI/2011/08/001944
CTRI/2011/08/001944招募中4 期

A Randomized control trial to study the effect of oral probiotic versus placebo in patients with ulcerative colitis on clinical/endoscopic response intestinal permeability and fecal and serum markers of mucosal inflammation in addition to standard therapy

Department of Biotechnology0 个研究点目标入组 72 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • Active disease at presentation

排除标准

  • Patient should not be on antibiotic, NSAIDs or indigenous medicine
  • Pregnant or lactating mother
  • Any patient who received probiotic in the preceding 4 weeks
  • Patient with life threatning cardiac, renal, pulmonary or cardiovascular disease
  • Inability to obtain informed consent
  • Severe disease requiring hospitalization /steroids /anti-cytokine therapy
  • Patient taking antiplatelet drugs
  • Patient with uncontrolled diabetes
  • patient with gall stone disease

研究者

发起方
Department of Biotechnology

相似试验